Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms

Vanishing bile duct syndrome (VBDS) is a rare disorder and requires a liver biopsy for a diagnosis. The condition has not been reported in children with toxic epidermal necrolysis (TEN). The etiology of VBDS in our patient with TEN is most likely from drug hypersensitivity. A high index of suspicion...

Full description

Bibliographic Details
Main Authors: Wikrom Karnsakul, Thaschawee Arkachaisri, Kanit Atisook, Wanee Wisuthsarewong, Yudhtana Sattawatthamrong, Prapun Aanpreung
Format: Article
Language:English
Published: Elsevier 2006-04-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119320290
id doaj-7e75cbfbfbbb4a608dca085419bf3ede
record_format Article
spelling doaj-7e75cbfbfbbb4a608dca085419bf3ede2021-06-08T04:36:19ZengElsevierAnnals of Hepatology1665-26812006-04-0152116119Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanismsWikrom Karnsakul0Thaschawee Arkachaisri1Kanit Atisook2Wanee Wisuthsarewong3Yudhtana Sattawatthamrong4Prapun Aanpreung5West Virginia University School of Medicine. Department of Pediatrics, Section of Gastroenterology and Nutrition, Morgantown, WV Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Pediatrics; Address for correspondence:Department of PediatricsDepartment of PathologyDepartment of PediatricsDepartment of Internal MedicineDepartment of PediatricsVanishing bile duct syndrome (VBDS) is a rare disorder and requires a liver biopsy for a diagnosis. The condition has not been reported in children with toxic epidermal necrolysis (TEN). The etiology of VBDS in our patient with TEN is most likely from drug hypersensitivity. A high index of suspicion will prompt clinicians to start more specific investigations and treatments. The use of immunosuppressive agents, intravenous immunoglobulin and ursodeoxycholic acid has not been consistently successful in these patients. A new approach with biologic agents such as anti-tumor necrosis factor-α may be a promising therapy and reduce severe adverse outcomes.http://www.sciencedirect.com/science/article/pii/S1665268119320290CholestasisductopeniaDrug rashtrimethoprim-sulfamethoxazole
collection DOAJ
language English
format Article
sources DOAJ
author Wikrom Karnsakul
Thaschawee Arkachaisri
Kanit Atisook
Wanee Wisuthsarewong
Yudhtana Sattawatthamrong
Prapun Aanpreung
spellingShingle Wikrom Karnsakul
Thaschawee Arkachaisri
Kanit Atisook
Wanee Wisuthsarewong
Yudhtana Sattawatthamrong
Prapun Aanpreung
Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
Annals of Hepatology
Cholestasis
ductopenia
Drug rash
trimethoprim-sulfamethoxazole
author_facet Wikrom Karnsakul
Thaschawee Arkachaisri
Kanit Atisook
Wanee Wisuthsarewong
Yudhtana Sattawatthamrong
Prapun Aanpreung
author_sort Wikrom Karnsakul
title Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
title_short Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
title_full Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
title_fullStr Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
title_full_unstemmed Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: An interplay of unbalanced immune regulatory mechanisms
title_sort vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms
publisher Elsevier
series Annals of Hepatology
issn 1665-2681
publishDate 2006-04-01
description Vanishing bile duct syndrome (VBDS) is a rare disorder and requires a liver biopsy for a diagnosis. The condition has not been reported in children with toxic epidermal necrolysis (TEN). The etiology of VBDS in our patient with TEN is most likely from drug hypersensitivity. A high index of suspicion will prompt clinicians to start more specific investigations and treatments. The use of immunosuppressive agents, intravenous immunoglobulin and ursodeoxycholic acid has not been consistently successful in these patients. A new approach with biologic agents such as anti-tumor necrosis factor-α may be a promising therapy and reduce severe adverse outcomes.
topic Cholestasis
ductopenia
Drug rash
trimethoprim-sulfamethoxazole
url http://www.sciencedirect.com/science/article/pii/S1665268119320290
work_keys_str_mv AT wikromkarnsakul vanishingbileductsyndromeinachildwithtoxicepidermalnecrolysisaninterplayofunbalancedimmuneregulatorymechanisms
AT thaschaweearkachaisri vanishingbileductsyndromeinachildwithtoxicepidermalnecrolysisaninterplayofunbalancedimmuneregulatorymechanisms
AT kanitatisook vanishingbileductsyndromeinachildwithtoxicepidermalnecrolysisaninterplayofunbalancedimmuneregulatorymechanisms
AT waneewisuthsarewong vanishingbileductsyndromeinachildwithtoxicepidermalnecrolysisaninterplayofunbalancedimmuneregulatorymechanisms
AT yudhtanasattawatthamrong vanishingbileductsyndromeinachildwithtoxicepidermalnecrolysisaninterplayofunbalancedimmuneregulatorymechanisms
AT prapunaanpreung vanishingbileductsyndromeinachildwithtoxicepidermalnecrolysisaninterplayofunbalancedimmuneregulatorymechanisms
_version_ 1721390927507881984